Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-23-279834
Filing Date
2023-11-17
Accepted
2023-11-17 16:38:26
Documents
1
Group Members
VERSANT VANTAGE II GP, L.P.VERSANT VANTAGE II GP-GP, LLCVERSANT VANTAGE II, L.P.VERSANT VENTURES VI GP, L.P.VERSANT VENTURES VI GP-GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d598930dsc13da.htm SC 13D/A 134701
  Complete submission text file 0001193125-23-279834.txt   136549
Mailing Address ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104
Business Address ONE SANSOME STREET, SUITE 1650 SAN FRANCISCO CA 94104 (415) 801-8100
Versant Venture Capital VI, L.P. (Filed by) CIK: 0001687880 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD, SUITE 120 SOUTH SAN FRANCISCO CA 94080 (650) 484-0886
Graphite Bio, Inc. (Subject) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92660 | Film No.: 231419390
SIC: 2836 Biological Products, (No Diagnostic Substances)